logo
  

Burberry Names Daniel Lee Chief Creative Officer, Succeeding Riccardo Tisci

Burberry Group Plc (BRBY.L), a British luxury fashion company, announced Wednesday the appointment of Daniel Lee as new Chief Creative Officer, effective October 3.

Lee succeeds Riccardo Tisci, who will be stepping down as Chief Creative Officer and leaving the firm at the end of this month after almost five years. Tisci's Spring Summer 2023 collection, presented this week in London, was his last for Burberry.

Lee will be based at Burberry's headquarters in London and report to Chief Executive Officer, Jonathan Akeroyd. In his new role, he will oversee all Burberry collections. He will present his debut runway collection at London Fashion Week in February 2023.

From 2018 to 2021, he served as Creative Director at Bottega Veneta, where he helped reinvigorate the Italian luxury brand. He was previously Director of ready-to-wear design at Celine, which he joined in 2012, and has also worked at Maison Margiela, Balenciaga and Donna Karan.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT